Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Palatin Announces First Patient Enrolled in Dry Eye Disease Trial with PL9643

americanpharmaceuticalreviewMarch 09, 2020

Tag: Palatin Technologies , PL9643 , Dry Eye Disease

PharmaSources Customer Service